ストックスクリーナーアプリを入手
78.79
7.61%
5.57
前日終値:
$73.22
開ける：
$75.26
24時間の取引高:
1.79M
Relative Volume:
1.37
時価総額：
$2.72B
収益：
$635.89M
当期純損益:
$171.92M
株価収益率:
18.08
EPS:
4.357
ネットキャッシュフロー:
$151.36M
1週間 パフォーマンス:
+7.07%
1か月 パフォーマンス:
+15.29%
6か月 パフォーマンス:
-34.92%
1年 パフォーマンス:
-36.46%
1日の値動き範囲:
$75.12
$80.72
1週間の範囲:
$71.33
$80.72
52週間の値動き範囲:
$60.10
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
名前
Transmedics Group Inc
セクター
電話
(978) 552-0900
住所
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
78.79 | 2.72B | 635.89M | 171.92M | 151.36M | 4.357 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-23 | アップグレード | Needham | Hold → Buy |
| 2025-10-13 | 開始されました | Jefferies | Buy |
| 2025-09-16 | 開始されました | Evercore ISI | Outperform |
| 2025-09-04 | 開始されました | Stifel | Hold |
| 2024-12-17 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-11-22 | ダウングレード | Needham | Buy → Hold |
| 2024-10-29 | 繰り返されました | Needham | Buy |
| 2024-10-29 | 繰り返されました | Oppenheimer | Outperform |
| 2024-09-24 | 開始されました | Robert W. Baird | Outperform |
| 2024-08-21 | 開始されました | Needham | Buy |
| 2024-06-06 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-06-04 | 開始されました | Stephens | Overweight |
| 2024-03-28 | 開始されました | Piper Sandler | Overweight |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2022-08-02 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-10-08 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-04-07 | 開始されました | Oppenheimer | Outperform |
| 2019-05-28 | 開始されました | Canaccord Genuity | Buy |
| 2019-05-28 | 開始されました | Cowen | Outperform |
| 2019-05-28 | 開始されました | JP Morgan | Overweight |
| 2019-05-28 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Transmedics Group Inc (TMDX) 最新ニュース
Virtu Financial LLC Buys 22,202 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
Lost Money on TransMedics Group, Inc.(TMDX)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - The National Law Review
TMDX Maintained by Stifel -- Price Target Raised to $80.00 - GuruFocus
TransMedics Group Jumps 6.6% Amid Sector-Wide Rally - AlphaStreet
Stifel raises TransMedics stock price target on strong flight data - Investing.com UK
TransMedics Group (NASDAQ:TMDX) Price Target Raised to $80.00 - MarketBeat
Why (TMDX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
TransMedics (TMDX) director exercises 19,285 options and sells shares - Stock Titan
Transmedics Group Inc (TMDX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Transmedics Group Inc (TMDX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Transmedics Group Inc (TMDX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Transmedics Group Inc (TMDX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Transmedics Group Inc (TMDX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Transmedics Group Inc (TMDX) Institutional Confidence - TradingKey
Transmedics Group Inc (TMDX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Transmedics Group Inc (TMDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Transmedics Group Inc (TMDX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
[144] TransMedics Group, Inc. SEC Filing - Stock Titan
Q1 2026 Transmedics Group Inc Earnings Call Transcript - GuruFocus
TMDX News | TRANSMEDICS GROUP INC (NASDAQ:TMDX) - ChartMill
Law firm investigates TransMedics after margin pressure and investment disclosures hurt stock price - Pluang
Johnson Fistel Investigates TransMedics Group, Inc. (TMDX) After Recent Disclosures Concerning ... - Enidnews.com
Johnson Fistel Investigates TransMedics Group, Inc. (TMDX) - GlobeNewswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims o - GuruFocus
TransMedics Group Jumps 5.8% Amid Sector-Wide Rally - AlphaStreet
TransMedics: Why I'm Still Bullish After The Collapse (NASDAQ:TMDX) - Seeking Alpha
TransMedics Group, Inc. Trade Ideas — XETR:8T8 - TradingView
Price to book ratio of TransMedics Group, Inc. – XETR:8T8 - TradingView
Will Analyst Focus on TransMedics’ OCS Platform and Financial Metrics Change TransMedics Group’s (TMDX) Narrative? - Yahoo Finance
TransMedics faces earnings test as jet fuel costs weigh By Investing.com - Investing.com Australia
TransMedics Group Inc Stock Operating Data - GuruFocus
Oppenheimer downgrades TransMedics stock rating on sentiment concerns - Investing.com
3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market - AOL.com
3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market - The Motley Fool
TransMedics Group Inc (NASDAQ:TMDX): An Affordable Growth Play With Strong Fundamentals - ChartMill
Earnings call transcript: TransMedics Q1 2026 misses EPS forecast, stock stable - Investing.com Australia
TransMedics Group, Inc. (TMDX) Presents at 46th Annual William Blair Growth Stock ConferenceSlideshow - Seeking Alpha
TransMedics (TMDX) Down 4.4% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Oppenheimer downgrades TransMedics stock rating on sentiment concerns By Investing.com - Investing.com UK
TMDX: Revolutionizing organ transplantation with record utilization rates and ambitious global growth targets - TradingView
TransMedics Group, Inc. (NASDAQ:TMDX) Given Average Rating of "Hold" by Brokerages - MarketBeat
TransMedics Group, Inc. (TMDX) Stock Analysis: A 73.78% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
Reasons to retain TransMedics stock in your portfolio for now - MSN
What Drove TransMedics' Stellar Q4 2025 Performance - Kavout
Is TransMedics Group Inc (TMDX) a Bargain After 3.3% Drop? GF Va - GuruFocus
Reasons to Retain TransMedics Stock in Your Portfolio for Now - Yahoo Finance
Retail Traders Swarm TransMedics After Q3 Print— Retail Bulls Call It A ‘Hardcore Dip Buy’ - MSN
Avoiding Lag: Real-Time Signals in (TMDX) Movement - Stock Traders Daily
TMDX Maintained by Stifel -- Price Target Lowered to $75.00 - GuruFocus
TransMedics Group Inc (TMDX) Stock Price, Trades & News - GuruFocus
Stifel Nicolaus Lowers TransMedics Group (NASDAQ:TMDX) Price Target to $75.00 - MarketBeat
Transmedics Group Inc (TMDX) 財務データ
収益
当期純利益
現金流量
EPS
Transmedics Group Inc (TMDX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Gunderson Thomas J. | Director |
Jun 15 '26 |
Sale |
75.06 |
9,624 |
722,377 |
16,642 |
0.93%
大文字化:
|
ボリューム (24 時間):